556 related articles for article (PubMed ID: 16522726)
1. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK
J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
Glister C; Kemp CF; Knight PG
Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
[TBL] [Abstract][Full Text] [Related]
3. Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line.
Farnworth PG; Stanton PG; Wang Y; Escalona R; Findlay JK; Ooi GT
Endocrinology; 2006 Jul; 147(7):3462-71. PubMed ID: 16601134
[TBL] [Abstract][Full Text] [Related]
4. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-6 enhances gonadotrophin-dependent progesterone and inhibin secretion and expression of mRNA transcripts encoding gonadotrophin receptors and inhibin/activin subunits in chicken granulosa cells.
Al-Musawi SL; Gladwell RT; Knight PG
Reproduction; 2007 Aug; 134(2):293-306. PubMed ID: 17660239
[TBL] [Abstract][Full Text] [Related]
6. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
Hofland J; Timmerman MA; de Herder WW; van Schaik RH; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
[TBL] [Abstract][Full Text] [Related]
7. Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells.
Vänttinen T; Kuulasmaa T; Liu J; Voutilainen R
J Clin Endocrinol Metab; 2002 Sep; 87(9):4257-63. PubMed ID: 12213882
[TBL] [Abstract][Full Text] [Related]
8. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.
Vänttinen T; Liu J; Kuulasmaa T; Kivinen P; Voutilainen R
J Endocrinol; 2003 Sep; 178(3):479-89. PubMed ID: 12967339
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization and mRNA expression of activin, inhibin, follistatin, and activin receptor in bovine cumulus-oocyte complexes during in vitro maturation.
Izadyar F; Dijkstra G; Van Tol HT; Van den Eijnden-van Raaij AJ; Van den Hurk R; Colenbrander B; Bevers MM
Mol Reprod Dev; 1998 Feb; 49(2):186-95. PubMed ID: 9444661
[TBL] [Abstract][Full Text] [Related]
10. Activins and inhibins and their signaling.
Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
[TBL] [Abstract][Full Text] [Related]
11. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors.
Chapman SC; Bernard DJ; Jelen J; Woodruff TK
Mol Cell Endocrinol; 2002 Oct; 196(1-2):79-93. PubMed ID: 12385827
[TBL] [Abstract][Full Text] [Related]
12. Inhibin binding sites and proteins in pituitary, gonadal, adrenal and bone cells.
Farnworth PG; Harrison CA; Leembruggen P; Chan KL; Stanton PG; Ooi GT; Rahman NA; Huhtaniemi IT; Findlay JK; Robertson DM
Mol Cell Endocrinol; 2001 Jun; 180(1-2):63-71. PubMed ID: 11451573
[TBL] [Abstract][Full Text] [Related]
13. Expression of bone morphogenetic proteins (BMPs), their receptors, and activins in normal and scarred conjunctiva: role of BMP-6 and activin-A in conjunctival scarring?
Andreev K; Zenkel M; Kruse F; Jünemann A; Schlötzer-Schrehardt U
Exp Eye Res; 2006 Nov; 83(5):1162-70. PubMed ID: 16879818
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the activin receptor in cultured rat hepatocytes.
Zhang YQ; Kanzaki M; Mashima H; Mine T; Kojima I
Hepatology; 1996 Aug; 24(2):446-50. PubMed ID: 8690418
[TBL] [Abstract][Full Text] [Related]
15. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
Lovell TM; Knight PG; Gladwell RT
J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664
[TBL] [Abstract][Full Text] [Related]
16. BMP-4 inhibits follicle-stimulating hormone secretion in ewe pituitary.
Faure MO; Nicol L; Fabre S; Fontaine J; Mohoric N; McNeilly A; Taragnat C
J Endocrinol; 2005 Jul; 186(1):109-21. PubMed ID: 16002541
[TBL] [Abstract][Full Text] [Related]
17. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the activin-inhibin-follistatin system by bone morphogenetic proteins in the zebrafish ovary.
Li CW; Ge W
Biol Reprod; 2013 Sep; 89(3):55. PubMed ID: 23843234
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
Farnworth PG; Wang Y; Escalona R; Leembruggen P; Ooi GT; Findlay JK
Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464
[TBL] [Abstract][Full Text] [Related]
20. Testing the antagonistic effect of follistatin on BMP family members in ovine granulosa cells.
Pierre A; Pisselet C; Monget P; Monniaux D; Fabre S
Reprod Nutr Dev; 2005; 45(4):419-25. PubMed ID: 16045890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
